scispace - formally typeset
R

Rodger Novak

Researcher at St. Jude Children's Research Hospital

Publications -  19
Citations -  1629

Rodger Novak is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Mutant & Streptococcus pneumoniae. The author has an hindex of 12, co-authored 19 publications receiving 1592 citations.

Papers
More filters
Journal ArticleDOI

Emergence of vancomycin tolerance in Streptococcus pneumoniae

TL;DR: It is concluded that broad antibiotic tolerance of S.pneumoniae has emerged in the community by a molecular mechanism that eliminates sensitivity to the current cornerstone of therapy, vancomycin.
Journal ArticleDOI

Neuroprotection by a caspase inhibitor in acute bacterial meningitis.

TL;DR: It is demonstrated that the broad-spectrum caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl-ketone (z-VAD-fmk) prevented hippocampal neuronal cell death and white blood cell influx into the cerebrospinal fluid compartment in experimental pneumococcal meningitis.
Journal ArticleDOI

Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages.

TL;DR: It is shown that a soluble toxin of Streptococcus pneumoniae, pneumolysin (Pln), is a key component initiating NO production from macrophage, and acts as an agonist of tumor necrosis factor alpha and interleukin 6 production in macrophages.
Journal ArticleDOI

Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis.

TL;DR: The Tupelo strain evidenced no lysis in the exponential or stationary phase of growth when exposed to vancomycin and only minimal loss of viability, indicating that the defect leading to tolerance in the Tupelo strains is in the control pathway for triggering of autolysis.